ArticleCellular and molecular life sciences : CMLS2025
Tip60-HDAC8-SMURF2-mediated β-TrCP1 degradation is a key mechanism for hypoxia-induced cell death and tissue injury.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
The accumulation of HIFs regulated by the PHD-pVHL pathway represents the classical mechanism that transcriptionally mediates cellular adaptation to hypoxia. Extensive hypoxic stress activates cell death. Comprehensive understanding the mechanisms of hypoxia-induced cell death is essential for treatment of several diseases. Here, we revealed that β-TrCP1 degradation is essential for hypoxia-induced cell death and tissue injury. Hypoxia promotes β-TrCP1 degradation via proteasome pathway in HIFs-independent manner, and SMURF2 is identified as the corresponding E3 ligase. Additionally, acetylation of β-TrCP1 decreases after hypoxia, which is required for β-TrCP1 degradation. Tip60 establishes the acetylation of β-TrCP1 under normoxic conditions and is prolyl-hydroxylated by PHD2. Prolyl Hydroxylation stabilizes Tip60 under normoxic conditions, while hypoxia promotes the degradation of Tip60 by decreasing its prolyl hydroxylation. HDAC8 catalyses the deacetylation of β-TrCP1, which is enhanced after hypoxia. Loss of β-TrCP1 acetylation after hypoxia promotes the binding of SMURF2 to β-TrCP1 and its degradation. p53 is a substrate of β-TrCP1, and loss of β-TrCP1 upon hypoxia results in the accumulation of p53, which is responsible for hypoxia-induced cell death and tissue injury. Thus, this study illustrates a previously unappreciated posttranscriptional hypoxia-responsive mechanism constituted by PHD2-Tip60-HDAC8-SMURF2-β-TrCP1 degradation axis to promote p53 accumulation to mediate cell death and tissue injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.